AI company Zebra Medical Vision has scored another approval from the FDA, this time for its AI alert that can help diagnose pneumothoraces based on chest X-rays.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.